Cancer cell possesses numerous adaptations to resist the immune system response and
chemotherapy. One of the most significant properties of the neoplastic cells is the altered …

Lysophosphatidylcholine (LPC) is increasingly recognized as a key marker/factor positively
associated with cardiovascular and neurodegenerative diseases. However, findings from …

To become resistant, cancer cells need to activate and maintain molecular defense
mechanisms that depend on an energy trade-off between resistance and essential functions …

Background: Ovarian cancer progression and invasiveness are promoted by a range of
soluble factors released by cancer cells and stromal cells within the tumor …

The present article examines recently published literature on lipids, mainly focusing on
research involving glycero-, glycerophospho-and sphingo-lipids. The primary aim is …

Background Ovarian cancer (OC) is a malignant neoplasm that displays increased
vascularization. Angiopoietin-like 4 (ANGPTL4) is a secreted glycoprotein that functions as a …

(1) Background: Biomarkers might play a significant role in predicting the clinical outcomes
of patients with ovarian cancer. By analyzing lipid metabolism genes, future perspectives …

Since the clear demonstration of lysophosphatidic acid (LPA)'s pathological roles in cancer
in the mid-1990s, more than 1000 papers relating LPA to various types of cancer were …

While cancer now impacts the health and well-being of more of the human population than
ever before, the exponential rise in antimicrobial resistant (AMR) bacterial infections means …

Epithelial Ovarian cancer (EOC) is the deadliest gynecologic malignancy and represents the
fifth leading cause of all cancer-related deaths in women. The majority of patients are …